Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1739

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 7A
Chunk 1739
---
 
    Preferred Stock  
    Common
    
    Stock(1)  
    Additional
    Paid-In  
    Accumulated  
    Accumulated
    Other Comprehensive  
    Total
    Shareholders’ Equity (Deficit) Attributable  
    Noncontrolling
    Interest on  
    Total
    
    Shareholders’ Equity 

    Shares  
    Amount  
    Shares  
    Amount  
    Capital(1)  
    Deficit  
    Income
    (Loss)  
    to
    60P  
    Shareholders  
    (Deficit) 
  
    Balance—December
    31, 2022 
     -  
    $-  
     39,768  
    $4  
    $5,164,696  
    $(28,815,148) 
    $73,708  
    $(23,576,740) 
    $(572,320) 
    $(24,149,060)
  
    Cancellation
    of common stock 
     -  
     -  
     (24,186) 
     (2) 
     2  
     -  
     -  
     -  
     -  
     - 
  
    Share-based
    compensation to vendors for services 
     -  
     -  
     24,717  
     3  
     5,683,053  
     -  
     -  
     5,683,056  
     -  
     5,683,056 
  
    Conversion
    of debt into common stock upon initial public offering 
     -  
     -  
     28,460  
     3  
     7,989,595  
     -  
     -  
     7,989,598  
     -  
     7,989,598 
  
    Conversion
    of debt into Series A Preferred Stock upon initial public offering 
     80,965  
     10,128,500  
     -  
     -  
     -  
     -  
     -  
     10,128,500  
     -  
     10,128,500